»» Searching for " SeattleGenetics "
 Related Search Tags:  SeattleGenetics SGEN Nasdaq:SGEN ADCETRIS Hodgkin NationalCancerInstitute USFDA
Showing Results 1-1 of 1 |  Sort by:     
Page 1 of 1  |  Go to page   
Thank you for joining us. I am your host Yohemy Auerbach at CRWE Newswire Stocks to watch. Seattle Genetics Incorporated - symbol SGEN - reported that the U.S. FDA has granted accelerated approval of ADCETRIS. ADCETRIS is the first approved by the FDA for Hodgkin lymphoma in more than 30 years, and provides a new therapeutic alternative for Hodgkin lymphoma and systemic anaplastic large cell lymphoma in these settings. Lymphoma is a general term for a group of cancers that originate in the lymphatic system. According to the National Cancer Institute, Estimated 8,830 new cases and 1,300 deaths from Hodgkin lymphoma in the United States in 2011. Seattle Genetics has U.S. and Canadian commercialization rights for adcetris. The company expects to make ADCETRIS available to patients in the next week. Thank you for tuning in, have a great day. For CRWE Newswire, Stocks to watch, I’m Yohemy Auerbach.
Seattle Genetics (SGEN)...
Categories: Videos 
Added: 275 days ago
By: karmastock
Runtime: 1m32s
Views: 82
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0822 seconds.